[1]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
|
[2]HILLMAN L, GOTTFRIED M, WHITSETT M, et al.Corrigendum:clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury[J].Am J Gastroenterol, 2016, 111 (10) :1504.
|
[3]BJORNSSON ES.Epidemiology and risk factors for idiosyncratic drug-induced liver injury[J].Semin Liver Dis, 2014, 34 (2) :115-122.
|
[4]BJRNSSON ES, BERGMANN OM, BJRNSSON HK, et al.Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland[J].Gastroenterology, 2013, 144 (7) :1419-1425.
|
[5]KLEINER DE.The pathology of drug-induced liver injury[J].Semin Liver Dis, 2009, 29 (4) :364-372.
|
[6]BREWER CT, CHEN T.Hepatotoxicity of herbal supplements mediated by modulation of cytochrome P450[J].Int J Mol Sci, 2017, 18 (11) .
|
[7]KLEINER DE.Drug-induced liver injury[J].Gastroenterol Clin North Am, 2017, 46 (2) :273-296.
|
[8]KLEINER DE.Histopathological challenges in suspected drug-induced liver injury[J].Liver Int, 2018, 38 (2) :198-209.
|
[9]HARADA K, HIEP NC, OHIRA H.Challenges and difficulties in pathological diagnosis of autoimmune hepatitis[J].Hepatol Res, 2017, 47 (10) :963-971.
|
[10]KLEINER DE, CHALASANI NP, LEE WM, et al.Hepatic histological findings in suspected drug-induced liver injury:Systematic evaluation and clinical associations[J].Hepatology, 2014, 59 (2) :661-670.
|
[11]KLEINER DE.The histopathological evaluation of drug-induced liver injury[J].Histopathology, 2017, 70 (1) :81-93.
|
[12]WANG L, ZHAO XY, MA H.Pathological features of drug-induced liver injury[J].Chin Hepatol, 2017, 22 (9) :837-840. (in Chinese) 王岚, 赵新颜, 马红.药物性肝损伤的病理学特征[J].肝脏, 2017, 22 (9) :837-840.
|
[13]JU HY, JANG JY, JEONG SW, et al.The clinical features of drug-induced liver injury observed through liver biopsy:Focus on relevancy to autoimmune hepatitis[J].Clin Mol Hepatol, 2012, 18 (2) :213-218.
|
[14]de BOER YS, KOSINSKI AS, URBAN TJ, et al.Features of autoimmune hepatitis in patients with drug-induced liver injury[J].Clin Gastroenterol Hepatol, 2017, 15 (1) :103-112.
|
[15]ZEN Y, YEH MM.Hepatotoxicity of immune checkpoint inhibitors:A histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury[J].Mod Pathol, 2018.[Epub ahead of print]
|
[16]BJORNSSON ES, JONASSON JG.Idiosyncratic drug-induced liver injury associated with bile duct loss and vanishing bile duct syndrome:Rare but has severe consequences[J].Hepatology, 2017, 65 (4) :1091-1093.
|
[17]ZHAO H, XIE W.Absence of bile duct or vanishing bile duct syndrome associated with idiosyncratic drug-induced liver injury:A rare disease with poor prognosis[J].Chin Hepatol, 2017, 22 (7) :576-577. (in Chinese) 赵红, 谢雯.特异质性药物性肝损伤相关的胆管缺失和胆管消失综合征:少见且预后不良[J].肝脏, 2017, 22 (7) :576-577.
|
[18]BONKOVSKY HL, KLEINER DE, GU J, et al.Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements[J].Hepatology, 2017, 65 (4) :1267-1277.
|
[19]GARCIA M, MHANNA MJ, CHUNG-PARK MJ, et al.Efficacy of early immunosuppressive therapy in a child with carbamazepineassociated vanishing bile duct and Stevens-Johnson syndromes[J].Dig Dis Sci, 2002, 47 (1) :177-182.
|
[20]KOOTTE AM, SIEGEL AM, KOORENHOF M.Generalised peliosis hepatis mimicking metastases after long-term use of oral contraceptives[J].Neth J Med, 2015, 73 (1) :41-43.
|
[21]FAN CQ, CRAWFORD JM.Sinusoidal obstruction syndrome (hepatic veno-occlusive disease) [J].J Clin Exp Hepatol, 2014, 4 (4) :332-346.
|